camptothecin has been researched along with Choriocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakuta, S; Kou, T; Sugaya, M; Takayama, W; Yanagibashi, H; Yoneyama, Y | 1 |
| Agrawal, S; Chen, J; Chen, L; Le, LP; Oliver, P; Wang, H; Zeng, X; Zhang, R; Zhou, W | 1 |
2 other study(ies) available for camptothecin and Choriocarcinoma
| Article | Year |
|---|---|
[Long-term survival and effective treatment of synchronous liver metastases in a case of primary gastric choriocarcinoma by using hepatic arterial infusion chemotherapy, irinotecan, and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Choriocarcinoma; Cisplatin; Fatal Outcome; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 2015 |
MDM2 oncogene as a target for cancer therapy: An antisense approach.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Choriocarcinoma; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nuclear Proteins; Oligonucleotides, Antisense; Osteosarcoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Survival Rate; Tumor Cells, Cultured | 1999 |